Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

130.61 -1.18 (-0.90%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,733,921
Open 132.32
Bid (Size) 130.30 (1)
Ask (Size) 130.75 (2)
Prev. Close 131.79
Today's Range 130.52 - 132.65
52wk Range 99.71 - 132.65
Shares Outstanding 1,750,942,289
Dividend Yield 1.68%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential. 
Via Benzinga
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
Via The Motley Fool

Performance

YTD
+15.14%
+15.14%
1 Month
+14.66%
+14.66%
3 Month
+11.29%
+11.29%
6 Month
+16.72%
+16.72%
1 Year
+14.56%
+14.56%

More News

Read More
Rep. Emily Randall Has Sold Up to $165K Worth Of Abbott Laboratories Stock: Here's What You Should Know
Via Benzinga
Looking Into Abbott Laboratories's Recent Short Interest
Via Benzinga
3 No-Brainer Healthcare Stocks to Buy With $200 Right Now
Via The Motley Fool
Q4 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Boston Scientific (NYSE:BSX)
Via StockStory
This Is What Whales Are Betting On Abbott Laboratories
Via Benzinga
Market Whales and Their Recent Bets on ABT Options
Via Benzinga
3 Fabulous Dividend Stocks to Buy in February
Via The Motley Fool
3 Dividend Growth Stocks For Intergenerational Wealth
Via Talk Markets
Topics Stocks / Equities
2 Unstoppable Dividend Stocks That Will Pay You for Life
Via The Motley Fool
AbbVie (NYSE:ABBV) Posts Better-Than-Expected Sales In Q4, Stock Soars
Via StockStory
Abbott Laboratories (NYSE:ABT) Posts Q4 Sales In Line With Estimates
Via StockStory
Deep Dive Into Abbott Laboratories Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Jim Cramer Is Worried About This Consumer Cyclical Stock: 7% Yield? 'Something May Be Wrong Here'
Via Benzinga
Abbott To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Abbott Laboratories Will Outperform Healthcare Stocks in 2025
Via MarketBeat
Why Is Abbott Stock Trading Higher On Thursday?
Via Benzinga
Congressional Trading Report: Rep. Thomas Kean Bought Over $1K In Abbott Laboratories Stock
Via Benzinga
US Stock Futures Trade Mixed After Skirting Record Highs In Last Session: GE Aerospace, American Airlines, Union Pacific In Focus
Via Benzinga
Topics Stocks
Exposures US Equities
My Top 5 Stocks to Buy in Early 2025
Via The Motley Fool
S&P 500 Hits New Record As Netflix Reports Strong Results: Investor Sentiment Improves But Greed Index Remains In 'Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
S&P 500 Hits Fresh Records At 6,100: Strong Earnings, Trump's AI Wager Fuel Bull Run
Via Benzinga
Topics Artificial Intelligence Government Stocks
Exposures Artificial Intelligence Political US Equities
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales
Via Benzinga
Exposures Fossil Fuels
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.